<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://www.w3.org/2005/Atom">
<title>Pulmonary Center Papers</title>
<link href="http://hdl.handle.net/2144/2445" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/2144/2445</id>
<updated>2013-06-19T11:01:36Z</updated>
<dc:date>2013-06-19T11:01:36Z</dc:date>
<entry>
<title>Growth Factors in Lung Development and Disease: Friends or Foe?</title>
<link href="http://hdl.handle.net/2144/3395" rel="alternate"/>
<author>
<name>Desai, Tushar J</name>
</author>
<author>
<name>Cardoso, Wellington V</name>
</author>
<id>http://hdl.handle.net/2144/3395</id>
<updated>2012-01-13T07:00:49Z</updated>
<published>2001-10-09T00:00:00Z</published>
<summary type="text">Growth Factors in Lung Development and Disease: Friends or Foe?
Desai, Tushar J; Cardoso, Wellington V
Growth factors mediate tissue interactions and regulate a variety of cellular functions that are critical for normal lung development and homeostasis. Besides their involvement in lung pattern formation, growth and cell differentiation during organogenesis, these factors have been also implicated in modulating injury-repair responses of the adult lung. Altered expression of growth factors, such as transforming growth factor β1, vascular endothelial growth factor and epidermal growth factor, and/or their receptors, has been found in a number of pathological lung conditions. In this paper, we discuss the dual role of these molecules in mediating beneficial feedback responses or responses that can further damage lung integrity; we shall also discuss the basis for their prospective use as therapeutic agents.
</summary>
<dc:date>2001-10-09T00:00:00Z</dc:date>
</entry>
<entry>
<title>RNAi Targeting of West Nile Virus in Mosquito Midguts Promotes Virus Diversification</title>
<link href="http://hdl.handle.net/2144/3393" rel="alternate"/>
<author>
<name>Brackney, Doug E.</name>
</author>
<author>
<name>Beane, Jennifer E.</name>
</author>
<author>
<name>Ebel, Gregory D.</name>
</author>
<id>http://hdl.handle.net/2144/3393</id>
<updated>2012-01-13T07:00:48Z</updated>
<published>2009-07-03T00:00:00Z</published>
<summary type="text">RNAi Targeting of West Nile Virus in Mosquito Midguts Promotes Virus Diversification
Brackney, Doug E.; Beane, Jennifer E.; Ebel, Gregory D.
West Nile virus (WNV) exists in nature as a genetically diverse population of competing genomes. This high genetic diversity and concomitant adaptive plasticity has facilitated the rapid adaptation of WNV to North American transmission cycles and contributed to its explosive spread throughout the New World. WNV is maintained in nature in a transmission cycle between mosquitoes and birds, with intrahost genetic diversity highest in mosquitoes. The mechanistic basis for this increase in genetic diversity in mosquitoes is poorly understood. To determine whether the high mutational diversity of WNV in mosquitoes is driven by RNA interference (RNAi), we characterized the RNAi response to WNV in the midguts of orally exposed Culex pipiens quinquefasciatus using high-throughput, massively parallel sequencing and estimated viral genetic diversity. Our data demonstrate that WNV infection in orally exposed vector mosquitoes induces the	RNAi pathway and that regions of the WNV genome that are more intensely targeted by RNAi are more likely to contain point mutations compared to weakly targeted regions. These results suggest that, under natural conditions, positive selection of WNV within mosquitoes is stronger in regions highly targeted by the host RNAi response. Further, they provide a mechanistic basis for the relative importance of mosquitoes in driving WNV diversification. Author SummaryWest Nile virus (WNV) was introduced into New York state in 1999 and has since spread across the Americas. It is transmitted in nature between adult female mosquitoes and birds and occasionally infects humans and horses. Within the host, WNV exists as a diverse assortment of closely related mutants. WNV populations within mosquitoes are more complex genetically than are those within birds. The reasons for this discrepancy are unknown, but may be related to the host's innate antivirus response. We demonstrate that WNV is targeted by RNA interference, a highly sequence-specific pathway in the mosquito. Further, we present data that correlates the intensity of this targeting with virus mutation under natural conditions. These results provide a mechanistic explanation for the increasead complexity of WNV populations in mosquitoes: the RNAi response creates an intracellular environment where rare genotypes are favored. In addition, our results suggest that genetically diverse WNV populations may have an advantage over less diverse populations because they present a more complex target for the RNAi response. Finally, these data suggest that WNV, and possibly other viruses with high mutation rates, may escape an engineered antivirus intervention that is highly sequence-specific.
</summary>
<dc:date>2009-07-03T00:00:00Z</dc:date>
</entry>
<entry>
<title>Role of Free Radicals in the Pathogenesis of Acute Chest Syndrome in Sickle Cell Disease</title>
<link href="http://hdl.handle.net/2144/3394" rel="alternate"/>
<author>
<name>Klings, Elizabeth S</name>
</author>
<author>
<name>Farber, Harrison W</name>
</author>
<id>http://hdl.handle.net/2144/3394</id>
<updated>2012-01-13T07:00:48Z</updated>
<published>2001-07-13T00:00:00Z</published>
<summary type="text">Role of Free Radicals in the Pathogenesis of Acute Chest Syndrome in Sickle Cell Disease
Klings, Elizabeth S; Farber, Harrison W
Acute chest syndrome (ACS) of sickle cell disease (SCD) is characterized pathologically by vaso-occlusive processes that result from abnormal interactions between sickle red blood cells (RBCs), white blood cells (WBCs) and/or platelets, and the vascular endothelium. One potential mechanism of vascular damage in ACS is by generation of oxygen-related molecules, such as superoxide (O2-), hydrogen peroxide (H2O2), peroxynitrite (ONOO-), and the hydroxyl (•OH) radical. The present review summarizes the evidence for alterations in oxidant stress during ACS of SCD, and the potential contributions of RBCs, WBCs and the vascular endothelium to this process.
</summary>
<dc:date>2001-07-13T00:00:00Z</dc:date>
</entry>
<entry>
<title>Production of IL-16 Correlates with CD4+ Th1 Inflammation and Phosphorylation of Axonal Cytoskeleton in Multiple Sclerosis Lesions</title>
<link href="http://hdl.handle.net/2144/3392" rel="alternate"/>
<author>
<name>Skundric, Dusanka S</name>
</author>
<author>
<name>Cai, Juan</name>
</author>
<author>
<name>Cruikshank, William W</name>
</author>
<author>
<name>Gveric, Djordje</name>
</author>
<id>http://hdl.handle.net/2144/3392</id>
<updated>2012-01-13T07:00:48Z</updated>
<published>2006-05-26T00:00:00Z</published>
<summary type="text">Production of IL-16 Correlates with CD4+ Th1 Inflammation and Phosphorylation of Axonal Cytoskeleton in Multiple Sclerosis Lesions
Skundric, Dusanka S; Cai, Juan; Cruikshank, William W; Gveric, Djordje
BACKGROUND
Multiple sclerosis (MS) is a central nervous system-specific autoimmune, demyelinating and neurodegenerative disease. Infiltration of lesions by autoaggressive, myelin-specific CD4+Th1 cells correlates with clinical manifestations of disease. The cytokine IL-16 is a CD4+ T cell-specific chemoattractant that is biased towards CD4+ Th1 cells. IL-16 precursor is constitutively expressed in lymphocytes and during CD4+ T cell activation; active caspase-3 cleaves and releases C-terminal bioactive IL-16. Previously, we used an animal model of MS to demonstrate an important role for IL-16 in regulation of autoimmune inflammation and subsequent axonal damage. This role of IL-16 in MS is largely unexplored. Here we examine the regulation of IL-16 in relation to CD4+ Th1 infiltration and inflammation-related changes of axonal cytoskeleton in MS lesions. 

METHODS
We measured relative levels of IL-16, active caspase-3, T-bet, Stat-1 (Tyr 701), and phosphorylated NF(M+H), in brain and spinal cord lesions from MS autopsies, using western blot analysis. We examined samples from 39 MS cases, which included acute, subacute and chronic lesions, as well as adjacent, normal-appearing white and grey matter. All samples were taken from patients with relapsing remitting clinical disease. We employed two-color immunostaining and confocal microscopy to identify phenotypes of IL-16-containing cells in frozen tissue sections from MS lesions. 

RESULTS
We found markedly increased levels of pro- and secreted IL-16 (80 kD and 22 kD, respectively) in MS lesions compared to controls. Levels of IL-16 peaked in acute, diminished in subacute, and were elevated again in chronic active lesions. Compared to lesions, lower but still appreciable IL-6 levels were measured in normal-appearing white matter adjacent to active lesions. Levels of IL-16 corresponded to increases in active-caspase-3, T-bet and phosphorylated Stat-1. In MS lesions, we readily observed IL-16 immunoreactivity confined to infiltrating CD3+, T-bet+ and active caspase-3+ mononuclear cells.

CONCLUSION
We present evidence suggesting that IL-16 production occurs in MS lesions. We show correlations between increased levels of secreted IL-16, CD4+ Th1 cell inflammation, and phosphorylation of axonal cytoskeleton in MS lesions. Overall, the data suggest a possible role for IL-16 in regulation of inflammation and of subsequent changes in the axonal cytoskeleton in MS.
</summary>
<dc:date>2006-05-26T00:00:00Z</dc:date>
</entry>
</feed>
